Tharimmune (THAR) Stock Chart & Stock Price History $1.64 -0.02 (-1.14%) As of 11:12 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tharimmune Stock Price Performance The Tharimmune (THAR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 55.05%, with a year-to-date return of -18.97%. In the past month, the stock has increased 22.76%, reflecting recent market activity. As of the latest close, Tharimmune traded at $1.66 with a market cap of $4.43 million and volume of 83,820 shares. Receive THAR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.30%1 Month Performance+22.76%3 Month Performance+41.81%Year-To-Date Performance-18.97%1 Year Performance-55.05% THAR Stock Chart for Tuesday, July, 22, 2025 THAR Chart by TradingView Tharimmune Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/21/2025$1.69$1.66-1.54%$1.70$1.6583,820 shs$4.43 million07/18/2025$1.65$1.69+2.42%$1.75$1.6770,254 shs$4.50 million07/17/2025$1.63$1.65+1.23%$1.74$1.6342,694 shs$4.39 million07/16/2025$1.68$1.63-2.98%$1.69$1.6145,535 shs$4.34 million07/15/2025$1.69$1.68-0.59%$1.82$1.60123,534 shs$4.47 million07/14/2025$1.73$1.69-2.31%$1.81$1.65109,430 shs$4.50 million07/11/2025$1.77$1.73-2.26%$1.80$1.7118,511 shs$4.60 million07/10/2025$1.76$1.77+0.57%$1.79$1.7024,034 shs$4.71 million07/09/2025$1.76$1.76$1.88$1.7314,131 shs$4.68 million07/08/2025$1.69$1.76+4.14%$1.85$1.709,300 shs$4.68 million Get the Latest News and Ratings for THAR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. 07/07/2025$1.84$1.69-7.95%$1.86$1.6075,268 shs$4.50 million07/04/2025$1.84$1.84$1.87$1.7312,482 shs$4.88 million07/03/2025$1.82$1.84+0.88%$1.87$1.7312,482 shs$4.88 million07/02/2025$1.78$1.82+2.25%$1.85$1.7517,040 shs$4.84 million07/01/2025$1.94$1.78-8.26%$1.96$1.7351,247 shs$4.74 million06/30/2025$1.80$1.94+7.64%$1.95$1.7968,397 shs$5.16 million06/27/2025$1.76$1.80+2.41%$1.85$1.7241,400 shs$4.80 million06/26/2025$1.66$1.76+6.03%$1.78$1.6152,769 shs$4.68 million06/25/2025$1.54$1.66+8.02%$1.75$1.53111,245 shs$4.42 million06/24/2025$1.31$1.54+17.31%$1.54$1.3874,562 shs$4.09 million06/23/2025$1.34$1.31-2.24%$1.36$1.3013,761 shs$3.49 million Related Companies Marker Therapeutics Stock Chart Hoth Therapeutics Stock Chart Aptorum Group Stock Chart Synlogic Stock Chart Lipocine Stock Chart Aspire Biopharma Stock Chart Carisma Therapeutics Stock Chart Citius Pharmaceuticals Stock Chart Gelteq Stock Chart Edesa Biotech Stock Chart Receive THAR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tharimmune and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:THAR) was last updated on 7/22/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tharimmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tharimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
